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Abstract 
Background: Colonization rate of Acinetobacter baumannii is increasing in hospitalized patients especially in long 
term hospitalized one and / or who were treat with extended spectrum antibiotics or anticancer. Antibiotic resistance 
in A. baumannii is considerable because more prevalence of them cause nosocomial infections and can impose high 
cost to health systems and patients. The aim of this study was determination of tigecycline, minocycline and colistin 
resistance A. baumannii in selected center in Tehran, Iran.  Materials and Methods: This study was descriptive and 
functional foundation. In this study A. baumannii were collected from Milad, Mofid, Taleghani, Motahari and 
Loghman hospital, Tehran and transferred to laboratory of pediatric infections research center. Collected bacteria 
were identified by conventional microbiology tests. Antibiotic susceptibility testing was determined according to 
CLSI guide line. Tigecycline, minocycline and colistin resistance strains were isolated.  Results: In this study, 105 
A. baumannii were collected from five selected hospitals: 48 (46%) from Milad, 33 (31%) from Motahari, 17 (16%) 
from Loghman, 4 (4%) from Mofid and 3 (3%) from Taleghani hospital. The highest resistance was observed against 
cefepime and high frequency of carbapenem and minocycline was observed. On the other hand, observed resistance 
to aminoglycosides was 93% at least. Tigecycline is the most effective antibiotic after colistin. Colistin resistant 
confirmed just in one isolate by E. test. Conclusion: The results of this study indicated that high rate of antibiotic 
resistance in A. baumannii even resistant to third and fourth generation of cephalosporin and carbapenem antibiotics. 
The treatment of MDR strains of A. baumannii become more complicated if the spread of them were not been 
controlled.  
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Colonization rate of Acinetobacter baumannii 
is increasing in hospitalized patient especially in 
patients who were hospitalized for a long time or 
who were treated with extended spectrum antibiotics 
or anti cancers [1, 2]. A. baumannii usually can 
involve in respiratory tract infection in hospitals. Also, 
A. baumannii can cause nosocomial urinary tract 
infections and wound infections, and even the 
infection can develop into septicemia [3]. Antibiotic 
resistance in A. baumannii is considerable that can be 
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intrinsic or it can be acquired through transferable 
genetic elements. Most strains of A. baumannii are 
resistant to ampicillin, amoxicillin-clavulanic acid, 
extended spectrum cephalosporins, tetracycline, 
macrolides and chloramphenicol. A. baumannii has 
presented various mechanisms for resistant to 
extended spectrum antibiotic. One of intrinsic 
resistance mechanism is mainly due to the low 
permeability of outer membrane and also structural 
expression of specific efflux pumps. A. baumannii 
can simply acquire genetic elements such as 
plasmids, transposons, and integrons [3- 8]. MDR 
isolates are being reported increasingly on the basis 
of so many studies that were done in developing and 
developed countries all over the world. Resistance to 
carbapenems, that are one of the last chances of 
antibiotic therapy in some cases, is also being seen 
[4, 7]. In some of the studies, the effect of 
combination therapy with tigecycline, colistin and 
minocycline in resistant cases is being discussed [9, 
11]. Because of prevalence of antibiotic resistant 
strains of A. baumannii in nosocomial infections and 
high costs of detection and especially treatment of 
this bacteria, more research and study about this are 
needed. Therefore, the aim of this study is 
determination of the prevalence of tigecycline, 
minocycline and colistin resistance A. baumannii in 
selected Medical centers in Tehran, Iran.  
Methods 
Bacterial strains. A. baumannii was collected 
from different clinical specimens (blood, urine, 
wound, sputum, etc.) of hospitalized patients in 
Taleghani, Motahari and Loghman hospitals in 2014. 
Identification of isolated A. baumannii strains by 
conventional microbiology and biochemistry 
methods such as oxidase, TSI, SIM, etc. 
         Antibiotic Susceptibility Testing.Determination 
of Antibiotic resistance pattern was prepared by disk 
diffusion method according to the CLSI protocol; 
minocycline (30µg), co-trimoxazole (1.25/23.75 µg), 
ceftazidime (30 µg), cefotaxime (30 µg ), gentamicin 
(10 µg ), ciprofloxacin(5 µg), amikacin (30 µg), 
imipenem (10 µg ), cefepime(30 µg), ceftriaxone (30 
µg ), meropenem (10 µg ), piperacillin- tazobactam 
(100/10 µg), tigecycline (15 µg). Determination of 
colistin resistant was determined MIC by E-Test.    
       Phenotypic ESBL detection. Combination disc 
method by clavulanic acid was used for the detection 
of ESBL producing strains according to CLSI 
guideline. In this method, cefotaxime and cefotaxime 
+ clavulanic acid and also ceftazidime and ceftazidime 
+ clavulanic acid discs were used. 
           Strains that have increase at least 5mm around 
the combined cephalosporin disc compare to 
cephalosporin alone were considered as an ESBL 
producing strains.   
Data analysis. In this study data analysis was 
done by SPSS 24. 
Results 
In this study, 105 A. baumannii strains were 
confirmed from five selected hospitals include; 48 
(46%) strains from Milad, 33 (31%) strains are from 
Motahari, 17 (16%) strains from Loghman hospital, 4 
(4%) strains from Mofid hospital and 3 (3%) strains 
from Taleghani hospital. Percentage of collected 
strains from different hospitals is demonstrated in the 
Figure 1. 
 
Antibiotic resistant percentage of A. baumannii 
strains are demonstrated in table 1. The rate of 
resistance and sensitivity of these bacteria to studied 
antibiotics is demonstrating that the highest rate of 
resistance belongs to cefotaxime with 100% rate and 
the highest rate of sensitivity belongs to tigecycline 
with 43.8% rate. 
According to table 1, the highest rate of 
resistance belongs to cefotaxime and the lowest rate of 




Figure 1. Collected Acinetobacter strains from different hospitals 
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Detection of ESBL.  Among the studied 
strains, 50 (48%) strains were confirmed as an ESBL 
producing strains by phenotypic method used in this 
study (figure 2).  
Study of colistin sensitivity by E- Test. In all 
strains studied in this research, MIC of colistin was 
determined by E-test antibiotic strips (figure 3). 
Except one strain that belongs to Motahari hospital, 
the rest are sensitive to this antibiotic. The MIC of 
resistant strain was 4mg concentration. 
 
Discussion 
       Gram-negative bacteria are always considered as 
one of the most important cause of nosocomial 
infections in health system. A. baumannii is one of the 
common non-fermenting gram-negative bacteria that 
is an agent of nosocomial infection especially in 
burned patients  .Nowadays, Antibiotic resistance has 
become an important challenge in treatment of 
infections caused by gram-negative bacteria such as A. 
baumannii [12- 19]. Over use and in some cases miss 
use of antibiotics in treatment of infections caused by 
this bacterial species can cause MDR strains to appear 
[12-15, 20, 21]. Prolonged hospitalization time of 
patients in hospital and imposing more costs on 
patients and also health system can be consequence 
results of high prevalence of MDR bacteria in 
hospitals [15, 21-23].  As results of this study 99% of 
studied strains have shown resistance to cefepime. 
Cefepime is a fourth generation cephalosporin and 
observation of such a high percentage of resistance to 
it can be considerable. On the other hand, the 
minimum observed resistance to tested 
aminoglycosides in this study is 93% and this 
resistance is very high and important. Thus, the reason 
and source of this observation must be follow ups. 
Also, resistance to minocycline and carbapenem of 
collected strains were more than 90%. Carbapenem 
and minocycline are the important therapeutic choices 
in serious infection caused by A.baumannii [21, 22]. 
Thus, identification of carbapenem resistant bacteria 
and diagnosis of resistance mechanism can be an 
important step for prevention of carbapenem and 
Table1. Antibiotic resistant frequency of collected A. 
baumannii 





























MN: minocycline ،SXT: co-trimoxazole ،CAZ: ceftazidime ،
CTX: cefotaxime ،GM:  gentamicin, CIP: ciprofloxacin ،AK: 
amikacin ،IMI: imipenem ،FEP: cefepime ،CTR: ceftriaxone ،
MRP: meropenem ،PTZ:piperacillin- tazobactam 
 
  




Figure 3. E-Test of colistin resistant strain 
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minocycline resistant bacteria spreading in the health 
centers. 
Owlia et al. studied on A. baumannii collected 
from burns in 2012. According to this study, 92% of 
strains were reported resistant to all tested beta 
lactam antibiotics [14].  
In 2011, Peymani et al. studied on 100 clinical 
samples of A. baumannii collected from different 
clinical samples of patients admitted in hospital in 
Tabriz. In this study, 92% resistance to ceftazidime, 
88% resistance to cefepime and 54% resistance to 
imipenem were reported [23] These rates are lower 
than the results of the current study. The reason for 
observed differences can be related to different 
therapeutic strategies in different hospitals or source 
of specimens.  
In the current study, results of resistance to 
beta-lactams and aminoglycosides which many of 
them are part of therapeutic choice of patients are 
also high and almost similar to results of some other 
studies in Iran [14, 15, 20, 21].  
Reason of this similarity can be related to 
similarity of strategy of antibiotic therapy in different 
parts of Iran. High rate of prescription of extended 
spectrum antibiotics for treating infection or in some 
cases incorrect use of extended spectrum antibiotics 
for prophylaxis in Iran may be possible cause of 
observed high frequency of antibiotic resistant 
bacteria in Iran. Hence, the use of extended spectrum 
antibiotics resulted in the selection of MDR bacteria 
and physician face to serious problematic antibiotic 
therapy. 
Results of a study in 2015, showed that in 
most cases, antibiotic prescription is without 
considering results of determination of antibiotic 
sensitivity testing of microbiology laboratory in 
hospital [24]. 
Iran is among world’s top 20 countries in drug 
use and ranks second after China in Asia. The most 
studies show 30 to 60 percent of prescribed drugs 
have been incorrect. Physicians, distributors or doing 
self-therapy may be involved in this health problem 
[25, 26]. 
Also in a study in Iran, in 2010, Dr. Gholami 
et al. studied on in emergency ward of educational 
hospital in Tehran [27].  
More than half of samples collected in recent 
study are from Motahari hospital and burn samples. 
Bacteria collected from burn patients showed high 
frequency of antibiotic resistance that can because of 
high rate prescription of extended spectrum antibiotics 
in this group of patients. 
Generally it should be noted that carbapenems 
are the last antibiotic choice in treatment of bacteria 
producing ESBL enzymes and in case of observation 
of carbapenem resistant bacteria which should be 
considered [23]. Another notable point in results of the 
current study is observation of a colistin resistant A. 
baumannii strain that according to MIC result.  
Colistin is the last antibiotic choice antibiotic in cases 
of carbapenem resistant and MDR or XDR A. 
baumannii infections. So, resistance to colistin is very 
serious and urgent problem in health system, 
especially in A. baumannii strains as one of the 
important nosocomial pathogens. On the other hand, 
molecular study on colistin resistant mechanisms is 
essential in this strain, because in 2016, plasmid born 
colistin resistance gene is reported from china [28]. 
Plasmid born colistin resistance can transfer 
horizontally to other bacteria and make unbelievable 
problem to antibiotic therapy. According to the results 
of the current study, more than half of collected A. 
baumannii were resistant to tigecycline.  Tigecycline 
also can be used to antibiotic therapy if MDR A. 
baumannii was isolated [29- 32] and observation of 
high resistant rate to this antibiotic can be consider in 
hospitalized patients. In different studies, therapeutic 
effect of tigecycline as monotherapy or combination 
with colistin or rifampin has been studied that in some 
cases, resistance to tigecycline is being reported [33]. 
Results of the current study showed that there is a high 
percentage of antibiotic resistance in studied A. 
baumannii strains. Even resistance to third and fourth 
generation cephalosporins and carbapenems is high 
and in case of not controlling these MDR strains in 
studied health centers, treatment of patients with A. 




Results of these studies show that collected A. 
baumannii from burn patients are not only resistant to 
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cephalosporins but also are highly resistant to 
imipenem. Observation of this high frequency of 
antibiotic resistance A. baumannii can be related to 
high use of carbapenem in treatment and sometimes 
use in prophylaxis with extended spectrum beta 
lactam antibiotics in these patients. 
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